Hydrogen inhalation ameliorates oxidative stress in transplantation induced intestinal graft injury.
Ischemia/reperfusion (I/R) injury during small intestinal transplantation (SITx) frequently causes complications including dysmotility, inflammation and organ failure. Recent evidence indicates hydrogen inhalation eliminates toxic hydroxyl radicals. Syngeneic, orthotopic SITx was performed in Lewis rats with 3 h of cold ischemic time. Both donor and recipient received perioperative air or 2% hydrogen inhalation. SITx caused a delay in gastrointestinal transit and decreased jejunal circular muscle contractile activity 24 h after surgery. Hydrogen treatment resulted in significantly improved gastrointestinal transit, as well as jejunal smooth muscle contractility in response to bethanechol. The transplant induced upregulation in the inflammatory mediators CCL2, IL-1 beta, IL-6 and TNF-alpha were mitigated by hydrogen. Hydrogen significantly diminished lipid peroxidation compared to elevated tissue malondialdehyde levels in air-treated grafts demonstrating an antioxidant effect. Histopathological mucosal erosion and increased gut permeability indicated a breakdown in posttransplant mucosal barrier function which was significantly attenuated by hydrogen treatment. In recipient lung, hydrogen treatment also resulted in a significant abatement in inflammatory mRNA induction and reduced neutrophil recruitment. Hydrogen inhalation significantly ameliorates intestinal transplant injury and prevents remote organ inflammation via its antioxidant effects. Administration of perioperative hydrogen gas may be a potent and clinically applicable therapeutic strategy for intestinal I/R injury.
Buchholz
B M
BM
Division of Gastroenterology, Department of Medicine, Hepatology and Nutrition, Thomas E Starzi Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Kaczorowski
D J
DJ
Sugimoto
R
R
Yang
R
R
Wang
Y
Y
Billiar
T R
TR
McCurry
K R
KR
Bauer
A J
AJ
Nakao
A
A
D000280:Administration, Inhalation; D000818:Animals; D000975:Antioxidants / Q000378:metabolism; D005740:Gases; D006859:Hydrogen / Q000008:administration & dosage / Q000627:therapeutic use*; D007249:Inflammation; D007422:Intestines / Q000473:pathology*; D008297:Male; D018384:Oxidative Stress; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D011917:Rats, Inbred Lew; D015427:Reperfusion Injury / Q000628:therapy*; D014180:Transplantation / Q000379:methods*; D019737:Transplants / Q000009:adverse effects
D000975:Antioxidants; D005740:Gases; D012333:RNA, Messenger; D006859:Hydrogen